Molecular 'feedback loop' may explain tamoxifen resistance in patients with breast ca
 

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer...

More...